Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 19, 2001
Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantationD H Kett, R C Acosta, M A Campos, et al.Chest|June 1, 1987
Complement activation and corticosteroid therapy in the development of the adult respiratory distress syndromeR M Schein, R Bergman, E H Marcial, et al.The American Review of Respiratory Disease|October 1, 1987
Distribution of proteins in pulmonary edema. The value of fractional concentrationsC L Sprung, W M Long, E H Marcial, et al.Critical Care Medicine|June 1, 1991
Amino acid alterations and encephalopathy in the sepsis syndromeC L Sprung, F B Cerra, H R Freund, et al.Critical Care Medicine|August 1, 1990
Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study GroupC L Sprung, P N Peduzzi, C H Shatney, et al.Chest|June 1, 1992
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care MedicineR C Bone, R A Balk, F B Cerra, et al.Critical Care Medicine|September 1, 1995
Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care MedicineB A Shapiro, J Warren, A B Egol, et al.Critical Care Medicine|September 1, 1995
Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: an executive summary. Society of Critical Care MedicineB A Shapiro, J Warren, A B Egol, et al.The New England Journal of Medicine|June 27, 1996
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study GroupC J Fisher, J M Agosti, S M Opal, et al.JAMA|August 28, 1991
A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study GroupR L Greenman, R M Schein, M A Martin, et al.Pageof 3